ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$1.98 USD
-0.02 (-1.00%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.96 -0.02 (-1.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 0.00% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.37 |
Next Year | -0.42 |
EPS (TTM) | -0.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.31M | 3.31M | 19.98M | 27.51M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 4.71M | 4.71M | 30.00M | 46.42M |
Low Estimate | 1.90M | 1.90M | 7.50M | 8.60M |
Year ago Sales | 0.70M | 1.31M | 7.04M | 19.98M |
Year over Year Growth Est. | 372.14% | 152.29% | 183.67% | 37.72% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.12 | -0.37 | -0.42 |
# of Estimates | 2 | 2 | 4 | 2 |
Most Recent Consensus | -0.12 | -0.12 | -0.32 | -0.54 |
High Estimate | -0.11 | -0.12 | -0.31 | -0.30 |
Low Estimate | -0.12 | -0.12 | -0.50 | -0.54 |
Year ago EPS | -0.12 | -0.11 | -0.38 | -0.37 |
Year over Year Growth Est. | 0.00% | -9.09% | 2.63% | -13.51% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.12 | -0.37 | -0.42 |
7 Days Ago | -0.12 | -0.12 | -0.37 | -0.42 |
30 Days Ago | -0.12 | -0.12 | -0.37 | -0.42 |
60 Days Ago | NA | NA | -0.34 | -0.33 |
90 Days Ago | -0.09 | -0.09 | -0.34 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.12 | -0.37 | -0.42 |
Zacks Consensus Estimate | -0.12 | -0.12 | -0.37 | -0.42 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.08 | -0.11 | -0.12 | NA |
Estimate | -0.08 | -0.06 | -0.12 | -0.12 | NA |
Difference | 0.00 | -0.02 | 0.01 | 0.00 | 0.00 |
Surprise | 0.00% | -33.33% | 8.33% | 0.00% | -6.25% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more